CareDx, Inc. (CDNA) said it expects preliminary fourth quarter revenue to be between $65 million and $66 million. Testing services revenue is expected to be between $46 million and $47 million, compared with $65.4 million in the same period in 2022.
The company anticipates preliminary revenue for the full year ended December 31, 2023, to be between $279 million and $280 million, a decrease of approximately 13% compared with $321.8 million in 2022, primarily driven by the impact of the Medicare Billing Article on Testing Services revenue. Testing services revenue is expected to be between $209 million and $210 million, compared with $263.7 million in 2022.
Preliminary cash, cash equivalents, and marketable securities were approximately $235 million as of December 31, 2023.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.